Intrathecal opioids block a spinal action of substance P in mice: functional importance of both mu- and delta-receptors

Eur J Pharmacol. 1982 Dec 17;86(1):95-8. doi: 10.1016/0014-2999(82)90403-4.

Abstract

Inhibition of intrathecal substance P-elicited behavior by mu-, delta- and kappa-opioids was compared. In both the substance P behavioral test and the tail flick antinociceptive test, intrathecal [D-Ala2, Met5]enkephalinamide and [D-Ala2, D-Leu5]enkephalin (DADL) were equipotent, morphine and ethylketazocine were less potent, but nalorphine was inactive. A long-lasting, highly selective, mu-receptor antagonist, beta-funaltrexamine, blocked the inhibition of substance P behaviors by both morphine and ethylketazocine, but did not block the effect of DADL. These results suggest that spinal postsynaptic modulation of nociception is mediated by both delta-type and mu-type opioid agonists.

Publication types

  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Animals
  • Cyclazocine / analogs & derivatives
  • Cyclazocine / pharmacology
  • Enkephalins / pharmacology
  • Ethylketocyclazocine
  • Injections, Spinal
  • Male
  • Mice
  • Morphine / pharmacology
  • Narcotics / administration & dosage
  • Narcotics / pharmacology*
  • Reaction Time / drug effects
  • Receptors, Opioid / drug effects*
  • Receptors, Opioid, delta
  • Receptors, Opioid, mu
  • Spinal Cord / drug effects*
  • Substance P / antagonists & inhibitors*
  • Synaptic Transmission / drug effects

Substances

  • Enkephalins
  • Narcotics
  • Receptors, Opioid
  • Receptors, Opioid, delta
  • Receptors, Opioid, mu
  • Substance P
  • Ethylketocyclazocine
  • Morphine
  • Cyclazocine